154 related articles for article (PubMed ID: 33506958)
1. Comparison of three modalities of plasmapheresis on coagulation: Centrifugal, single-membrane filtration, and double-filtration plasmapheresis.
Marlu R; Naciri Bennani H; Seyve L; Noble J; Chevallier E; Motte L; Imerzoukene F; Bugnazet M; Christophe M; Malvezzi P; Jouve T; Rostaing L
J Clin Apher; 2021 Jun; 36(3):408-419. PubMed ID: 33506958
[TBL] [Abstract][Full Text] [Related]
2. Effect of double-filtration plasmapheresis for antibody-mediated rejection on hemostasis parameters and thrombin generation.
Marlu R; Malvezzi P; Seyve L; Jouve T; Maurizi J; Defendi F; Carron PL; Christophe M; Le Gouellec A; Polack B; Rostaing L
Thromb Res; 2018 Jun; 166():113-121. PubMed ID: 29747114
[TBL] [Abstract][Full Text] [Related]
3. Comparison of centrifugal and membrane filtration modalities on therapeutic plasma exchange.
Keklik M; Çelik S; Yıldızhan E
J Clin Apher; 2022 Jun; 37(3):217-222. PubMed ID: 34978347
[TBL] [Abstract][Full Text] [Related]
4. Isoagglutinin removal by plasma centrifugation or filtration (single or double): A prospective study in a single center.
Naciri Bennani H; Noble J; Chevallier E; Terrec F; Motte L; Giroux-Lathuile C; Bugnazet M; Imerzoukene F; Janbon B; Malvezzi P; Rostaing L; Jouve T
J Clin Apher; 2021 Feb; 36(1):149-160. PubMed ID: 33230824
[TBL] [Abstract][Full Text] [Related]
5. Effect of immunoadsorption alone or combined with membrane filtration on hemostasis parameters.
Marlu R; Bennani HN; Seyve L; Malvezzi P; Janbon B; Noble J; Christophe M; Motte L; Imerzoukene F; Chevallier E; Rostaing L; Jouve T
J Clin Apher; 2020 Sep; 35(5):444-452. PubMed ID: 32805070
[TBL] [Abstract][Full Text] [Related]
6. How to improve clotting factors depletion in double-filtration plasmapheresis.
Naciri Bennani H; Marlu R; Terrec F; Motte L; Seyve L; Chevallier E; Malvezzi P; Jouve T; Rostaing L; Noble J
J Clin Apher; 2021 Oct; 36(5):766-774. PubMed ID: 34339059
[TBL] [Abstract][Full Text] [Related]
7. Membrane versus centrifuge-based therapeutic plasma exchange: a randomized prospective crossover study.
Hafer C; Golla P; Gericke M; Eden G; Beutel G; Schmidt JJ; Schmidt BM; De Reys S; Kielstein JT
Int Urol Nephrol; 2016 Jan; 48(1):133-8. PubMed ID: 26531062
[TBL] [Abstract][Full Text] [Related]
8. Optimization of heparinization in clinical double filtration plasmapheresis.
Hosokawa S; Oyamaguchi A; Yoshida O
Int J Artif Organs; 1989 Aug; 12(8):544-8. PubMed ID: 2807601
[TBL] [Abstract][Full Text] [Related]
9. The impact of therapeutic plasma exchange and double filtration plasmapheresis on hemostasis in renal transplant recipients.
Vatazin AV; Zulkarnaev AB
Ter Arkh; 2018 Jun; 90(6):22-27. PubMed ID: 30701900
[TBL] [Abstract][Full Text] [Related]
10. Retrospective analysis comparing complication rates of centrifuge vs membrane-based therapeutic plasma exchange in the pediatric population.
Webb TN; Bell J; Griffin R; Dill L; Gurosky C; Askenazi D
J Clin Apher; 2022 Jun; 37(3):263-272. PubMed ID: 35137962
[TBL] [Abstract][Full Text] [Related]
11. Membrane-based therapeutic plasma exchange (mTPE): Technical and clinical experience.
Gashti CN; Andreoli DC; Patel D
J Clin Apher; 2018 Feb; 33(1):38-45. PubMed ID: 28608569
[TBL] [Abstract][Full Text] [Related]
12. Regional Citrate Anticoagulation during Double-Filtration Plasmapheresis in Kidney Transplant Recipients: A Single-Center Retrospective Cohort Study.
Ho QY; Teh SP; Thangaraju S; Teo SH; Tan HK; Abdul Rahman MB; Ng LC; Lim AEL; Choong LHL; Kee T; Kaushik M;
Blood Purif; 2022; 51(4):376-382. PubMed ID: 34198288
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of theefficacy of removal of anti-ABO and anti-gal antibodies by double filtration plasmapheresis.
Kobayashi T; Yokoyama I; Morozumi K; Nagasaka T; Hayashi S; Uchida K; Takagi H; Nakao A
Xenotransplantation; 2000 May; 7(2):101-8. PubMed ID: 10961294
[TBL] [Abstract][Full Text] [Related]
14. Double filtration plasmapheresis for children with different types of critical kidney diseases: a single-center retrospective cohort study.
Zhang Y; Xie Q; Chen Y; Yang J; Huang S; Deng L; Zhou J
Transl Pediatr; 2023 Mar; 12(3):354-363. PubMed ID: 37035407
[TBL] [Abstract][Full Text] [Related]
15. Reducing Fibrinogen and Factor XIII Using Double-Filtration Plasmapheresis for Antibody-Mediated Rejection: Predictive Models.
Jouve T; Marlu R; Malvezzi P; Seyve L; Maurizi J; Carron PL; Polack B; Rostaing L
Blood Purif; 2018; 46(3):239-245. PubMed ID: 29972828
[TBL] [Abstract][Full Text] [Related]
16. Double-filtration plasmapheresis.
Tanabe K
Transplantation; 2007 Dec; 84(12 Suppl):S30-2. PubMed ID: 18162985
[TBL] [Abstract][Full Text] [Related]
17. Non-tolerability of double-filtration plasmapheresis in antibody-incompatible kidney transplant candidates.
Hebibi H; Weclawiak H; Rostaing L; Beaudreuil S; Allal A; François H; Durrbach A; Kamar N
Saudi J Kidney Dis Transpl; 2015 Mar; 26(2):297-301. PubMed ID: 25758878
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen reconstitution after therapeutic apheresis: Comparison of double-filtration plasmapheresis, plasma exchange, and immunoadsorption.
Jouve T; Marlu R; Naciri Bennani H; Noble J; Chevallier E; Motte L; Imerzoukene F; Malvezzi P; Rostaing L
J Clin Apher; 2021 Aug; 36(4):574-583. PubMed ID: 33783856
[TBL] [Abstract][Full Text] [Related]
19. Double filtration plasmapheresis can decrease factor XIII Activity.
Hanafusa N; Kondo Y; Suzuki M; Nakao A; Noiri E; Fujita T
Ther Apher Dial; 2007 Jun; 11(3):165-70. PubMed ID: 17497996
[TBL] [Abstract][Full Text] [Related]
20. Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis.
Sawada T; Fuchinoue S; Teraoka S
Transplantation; 2002 Nov; 74(9):1207-10. PubMed ID: 12451255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
